FrancophonIA/ELRC3.0 huggingface dataset:
English: Inhixa 10,000 IU (100 mg)/1 mL is 1 mL of solution in: - a clear, colourless type I neutral glass graduated syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a black polypropylene plunger rod.
Croatian: Inhixa 10,000 IU (100 mg)/1 ml jest 1 ml otopine u: - graduiranoj štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i crnim klipom od polipropilena, s pričvršćenom iglom i pokrovom za iglu.
English: Thrombocytopenia and thrombocytosis System Organ
Croatian: Trombocitopenija i tromboza
English: Inhixa 12,000 IU (120 mg)/0.8 mL injection enoxaparin sodium
Croatian: Inhixa 12 000 IU (120 mg)/0,8 ml otopina za injekciju enoksaparinnatrij
English: Each pre-filled syringe contains enoxaparin sodium 10,000 IU anti-Xa activity (equivalent to 100 mg) in 1 mL water for injections.
Croatian: Jedna napunjena štrcaljka sadrži 10 000 IU anti-Xa aktivnosti enoksaparinnatrija (što odgovara 100 mg) u 1 ml vode za injekcije.
English: Inhixa 8,000 IU (80 mg)/0.8 mL injection enoxaparin sodium
Croatian: Inhixa 8000 IU (80 mg)/0,8 ml otopina za injekciju enoksaparinnatrij
English: The air bubble should not be expelled from the syringe before the injection to avoid the loss of drug when using pre-filled syringes.
Croatian: Kako ne bi došlo do gubitka lijeka kod uporabe napunjenih štrcaljki, prije primjene injekcije ne smije se uklanjati mjehurić zraka iz štrcaljke.
English: Inhixa 4,000 IU (40 mg) /0.4 mL injection enoxaparin sodium
Croatian: Inhixa 4000 IU (40 mg)/0,4 ml otopina za injekciju enoksaparinnatrij
English: The syringe can be additionally equipped with needle guard; or - a clear, colourless type I neutral glass graduated syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a white polycarbonate plunger rod equipped with UltraSafe Passive needle guard.
Croatian: Štrcaljka može biti dodatno opremljena štitnikom za iglu; ili - graduiranoj štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i bijelim polikarbonatnim klipom, s pričvršćenom iglom pokrovom za iglu, opremljenoj UltraSafe Passive štitnikom za iglu.
English: Each pre-filled syringe contains enoxaparin sodium 2,000 IU anti-Xa activity (equivalent to 20 mg) in 0.2 mL water for injections.
Croatian: Jedna napunjena štrcaljka sadrži 2000 IU anti-Xa aktivnosti enoksaparinnatrija (što odgovara 20 mg) u 0,2 ml vode za injekcije.
English: Each mL contains 10,000 IU (100 mg) enoxaparin sodium.
Croatian: Jedan ml sadrži 10 000 IU (100 mg) enoksaparinnatrija.
English: Switch between enoxaparin sodium and vitamin K antagonists (VKA) Clinical monitoring and laboratory tests [prothrombin time expressed as the International Normalized Ratio (INR)] must be intensified to monitor the effect of VKA.
Croatian: Prelazak s enoksaparinnatrija na antagoniste vitamina K i obratno Kliničko praćenje i laboratorijske pretrage (protrombinsko vrijeme izraženo kao internacionalni normalizirani omjer [engl. international normalized ratio, INR] moraju se intenzivirati radi praćenja učinka antagonista vitamina K.
English: One pre-filled syringe (0.8 mL) contains 8,000 IU (80 mg) enoxaparin sodium
Croatian: Jedna napunjena štrcaljka (0,8 ml) sadrži 8000 IU (80 mg) enoksaparinnatrija.
English: Inhixa 6,000 IU (60 mg)/0.6 mL injection enoxaparin sodium
Croatian: Inhixa 6000 IU (60 mg)/0,6 ml otopina za injekciju enoksaparinnatrij
English: Each pre-filled syringe of 0.2 mL contains 2,000 IU (20 mg) of enoxaparin sodium.
Croatian: Jedna napunjena štrcaljka od 0,2 ml sadrži 2000 IU (20 mg) enoksaparinnatrija.
English: Volume to be injected through intravenous line after dilution is completed at a concentration of 300 IU (3 mg)/mL.
Croatian: Volumen koji treba injicirati kroz intravensku liniju nakon završetka razrjeđivanja do koncentracije od 300 IU (3 mg)/ml.
English: The complete contents of the 6,000 IU (60 mg) enoxaparin sodium pre-filled syringe should be injected into the 20 mL remaining in the bag.
Croatian: Injicirati sav sadržaj napunjene štrcaljke sa 6000 IU (60 mg) enoksaparinnatrija u 20 ml otopine koja je preostala u vrećici.
English: Each pre-filled syringe of 1 mL contains 10,000 IU (100 mg) of enoxaparin sodium.
Croatian: Jedna napunjena štrcaljka od 1 ml sadrži 10 000 IU (100 mg) enoksaparinnatrija.
English: haemorrhage, hypersensitivity, inflammation, mass, pain, or reaction) o Uncommon: Local irritation, skin necrosis at injection site
Croatian: Opći poremećaji i reakcije na mjestu primjene o Često: hematom na mjestu injiciranja, bol na mjestu injiciranja, ostale reakcije na mjestu injiciranja (kao što su edem, krvarenje, preosjetljivost, upala, masa, bol ili reakcija) o Manje često: lokalna nadraženost; nekroza kože na mjestu injiciranja
English: Supplied in packs of: - 2, 10 and 30 pre-filled syringes, - 10 and 30 pre-filled syringes with needle guard.
Croatian: Dostupno u pakiranjima od: - 2, 10 i 30 napunjenih štrcaljke - 10 i 30 napunjenih štrcaljki sa štitnikom
English: One vial (10 mL) contains 100,000 IU (1000 mg) enoxaparin sodium.
Croatian: Jedna bočica (10 ml) sadrži 100 000 IU (1000 mg) enoksaparinnatrija.
English: Inhixa 50,000 IU (500 mg)/5 mL solution for injection in multidose vial enoxaparin sodium
Croatian: Inhixa 50 000 IU (500 mg)/5 ml otopina za injekciju u višedoznoj bočici enoksaparinnatrij
English: The syringe can be additionally equipped with needle guard; or - a clear, colourless type I neutral glass syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a white polycarbonate plunger rod equipped with UltraSafe Passive needle guard.
Croatian: Štrcaljka može biti dodatno opremljena štitnikom za iglu; ili - štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i bijelim polikarbonatnim klipom opremljenoj UltraSafe Passive štitnikom za iglu, s pričvršćenom iglom i pokrovom za iglu.
English: One pre-filled syringe (1 mL) contains 10,000 IU (100 mg) enoxaparin sodium
Croatian: Jedna napunjena štrcaljka (1 ml) sadrži 10 000 IU (100 mg) enoksaparinnatrija.
English: Inhixa 2,000 IU (20 mg)/0.2 mL solution for injection enoxaparin sodium
Croatian: Inhixa 2000 IU (20 mg)/0,2 ml otopina za injekciju enoksaparinnatrij
English: VTE = venous thromboembolic event (DVT and/or PE) *The 95% Confidence Intervals for the treatment differences for total VTE were: - enoxaparin sodium once a day versus heparin (-3.0 to 3.5) - enoxaparin sodium every 12 hours versus heparin (-4.2 to 1.7).
Croatian: VTE = venski tromboembolijski događaj (DVT i/ili PE) *Intervali pouzdanosti od 95% za razlike između liječenja za ukupni VTE bili su: - enoksaparinnatrij jedanput na dan naspram heparina ( -3,0 do 3,5) - enoksaparinnatrij svakih 12 sati naspram heparina ( -4,2 do 1,7).
English: A 3,000 IU (30 mg) intravenous bolus immediately followed by a 100 IU/kg (1 mg/kg) subcutaneous every 12 hours provided initial maximum anti-Xa activity level of 1.16 IU/mL (n=16) and average exposure corresponding to 88% of steady-state levels.
Croatian: Intravenska bolusna doza od 3000 IU (30 mg) i neposredno zatim supkutane doze od 100 IU/kg (1 mg/kg) svakih 12 sati dovele su do početne vršne anti-Xa aktivnosti od 1,16 IU/ml (n = 16) i prosječne izloženosti koja je iznosila 88% razine u stanju dinamičke ravnoteže.
English: A 3,000 IU (30 mg) intravenous bolus immediately followed by a 100 IU/kg (1 mg/kg) subcutaneous every 12 hours provided initial maximum anti-Xa activity level of 1.16 IU/mL (n = 16) and average exposure corresponding to 88% of steady-state levels.
Croatian: Intravenska bolusna doza od 3000 IU (30 mg) i neposredno zatim supkutane doze od 100 IU/kg (1 mg/kg) svakih 12 sati dovele su do početne vršne anti-Xa aktivnosti od 1,16 IU/ml (n=16) i prosječne izloženosti koja je iznosila 88% razine u stanju dinamičke ravnoteže.
English: No dose adjustment is recommended in patients with moderate (creatinine clearance 30-50 mL/min) and mild (creatinine clearance 50-80 mL/min) renal impairment.
Croatian: Ne preporučuje se prilagodba doze u bolesnika s umjerenim (klirens kreatinina: 30 - 50 ml/min) i blagim (klirens kreatinina: 50-80 ml/min) oštećenjem bubrežne funkcije.
English: Volume to inject when diluted to a final concentration of 300 IU (3 mg)/mL
Croatian: Volumen koji treba injicirati nakon razrjeđivanja do konačne koncentracije od 300 IU (3 mg)/ml
English: Because of the content of benzyl alcohol (see section 6.1), enoxaparin sodium multiple dose vial formulation must not be given to newborns or premature neonates (see sections 4.4 and 4.6).
Croatian: • spinalnom ili epiduralnom anestezijom ili lokoregionalnom anestezijom kada je enoksaparinnatrij primijenjen za liječenje unutar prethodna 24 sata (vidjeti dio 4.4) Zbog sadržaja benzilnog alkohola (vidjeti dio 6.1) formulacija enoksaparinnatrija u višedoznoj bočici ne smije se dati novorođenčadi ili nedonoščadi (vidjeti dijelove 4.4 i 4.6).
English: Inhixa 100,000 IU (1000 mg)/10 mL solution for injection in multidose vial enoxaparin sodium
Croatian: Inhixa 100 000 IU (1000 mg)/10 ml otopina za injekciju u višedoznoj bočici enoksaparinnatrij
English: 2 pre-filled syringes with needle guard 5 pre-filled syringes with needle guard 6 pre-filled syringes with needle guard 10 pre-filled syringes with needle guard 20 pre-filled syringes with needle guard 30 pre-filled syringes with needle guard 50 pre-filled syringes with needle guard 90 pre-filled syringes with needle guard 2 pre-filled syringes with UltraSafe Passive needle guard 6 pre-filled syringes with UltraSafe Passive needle guard
Croatian: 2 napunjene štrcaljke sa štitnikom za iglu 5 napunjenih štrcaljki sa štitnikom za iglu 6 napunjenih štrcaljki sa štitnikom za iglu 10 napunjenih štrcaljki sa štitnikom za iglu 20 napunjenih štrcaljki sa štitnikom za iglu 30 napunjenih štrcaljki sa štitnikom za iglu 50 napunjenih štrcaljki sa štitnikom za iglu 90 napunjenih štrcaljki sa štitnikom za iglu 2 napunjene štrcaljke sa UltraSafe Passive štitnikom za iglu 6 napunjenih štrcaljki sa UltraSafe Passive štitnikom za iglu
English: Enoxaparin sodium may be safely administered with sodium chloride 9 mg/mL (0.9%) solution for infusion or 5% glucose in water for injections.
Croatian: Enoksaparinnatrij se može sigurno primjenjivati zajedno s otopinom natrijeva klorida od 9 mg/ml (0,9 %) za infuziju ili 5 %-tnom vodenom otopinom glukoze za injekcije.
English: In a second double-blind study, 262 patients without VTE disease and undergoing hip replacement surgery initially treated, while hospitalized, with enoxaparin sodium 4,000 IU (40 mg) subcutaneously were randomized to a post-discharge regimen of either enoxaparin sodium 4,000 IU (40 mg) (n = 131) once a day subcutaneously or to placebo (n = 131) for 3 weeks.
Croatian: U drugom dvostruko slijepom ispitivanju, 262 bolesnika bez VTE-a podvrgnuta kirurškom zahvatu zamjene kuka, koja su prvotno (tijekom hospitalizacije) bila liječena enoksaparinnatrijem u supkutanoj dozi od 4000 IU (40 mg), randomizirana su da nakon otpuštanja iz bolnice primaju enoksaparinnatrij u dozi od 4000 IU (40 mg) (n = 131) supkutano jedanput na dan ili placebo (n = 131) tijekom 3 tjedna.
English: In a second double-blind study, 262 patients without VTE disease and undergoing hip replacement surgery initially treated, while hospitalized, with enoxaparin sodium 4,000 IU (40 mg) subcutaneously were randomized to a post-discharge regimen of either enoxaparin sodium 4,000 IU (40 mg) (n=131) once a day subcutaneously or to placebo (n=131) for 3 weeks.
Croatian: U drugom dvostruko slijepom ispitivanju, 262 bolesnika bez VTE-a podvrgnuta kirurškom zahvatu zamjene kuka, koja su prvotno (tijekom hospitalizacije) bila liječena enoksaparinnatrijem u supkutanoj dozi od 4000 IU (40 mg), randomizirana su da nakon otpuštanja iz bolnice primaju enoksaparinnatrij u dozi od 4000 IU (40 mg) (n=131) supkutano jedanput na dan ili placebo (n=131) tijekom 3 tjedna.
English: There is a lower weightadjusted clearance in obese subjects with subcutaneous dosing.
Croatian: Klirens prilagođen prema tjelesnoj težini u pretilih ispitanika manji je kod supkutane primjene.
English: What Inhixa looks like and contents of the pack Inhixa 12,000 IU (120 mg)/0.8 mL is 0.8 mL of solution in: - a clear, colourless type I neutral glass syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a purple polypropylene plunger rod.
Croatian: Inhixa 12 000 IU (120 mg)/0,8 ml jest 0,8 ml otopine u: štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil gume i ljubičastim klipom od polipropilena s pričvršćenom iglom i pokrovom za iglu.
English: 2 pre-filled syringes with needle guard 6 pre-filled syringes with needle guard 10 pre-filled syringes with needle guard 12 pre-filled syringes with needle guard 24 pre-filled syringes with needle guard 30 pre-filled syringes with needle guard 2 pre-filled syringes with UltraSafe Passive needle guard 10 pre-filled syringes with UltraSafe Passive needle guard
Croatian: 2 napunjene štrcaljke sa štitnikom za iglu 6 napunjenih štrcaljki sa štitnikom za iglu 10 napunjenih štrcaljki sa štitnikom za iglu 12 napunjenih štrcaljki sa štitnikom za iglu 24 napunjenih štrcaljki sa štitnikom za iglu 30 napunjenih štrcaljki sa štitnikom za iglu 2 napunjene štrcaljke sa UltraSafe Passive štitnikom za iglu 10 napunjenih štrcaljki sa UltraSafe Passive štitnikom za iglu
English: 0.8 mL of solution in: - a clear, colourless type I neutral glass graduated syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a red polypropylene plunger rod.
Croatian: 0,8 ml otopine u: graduiranoj štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i crvenim klipom od polipropilena s pričvršćenom iglom i pokrovom za iglu.
English: Packs of: - 2, 5, 6, 10, 30 and 50 pre-filled syringes - 2, 5, 6, 10, 20, 30, 50 and 90 pre-filled syringes with needle guard - 2 and 6 pre-filled syringes with UltraSafe Passive needle guard
Croatian: Pakiranja od: - 2, 5, 6, 10, 30 i 50 napunjenih štrcaljki - 2, 5, 6, 10, 20, 30, 50 i 90 napunjenih štrcaljki sa štitnika za iglu - 2 i 6 napunjenih štrcaljki sa UltraSafe Passive štitnika za iglu
English: 0.2 mL of solution in: - a clear, colourless type I neutral glass syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a blue polypropylene plunger rod.
Croatian: 0,2 ml otopine u: štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i plavim klipom od polipropilena s pričvršćenom iglom i pokrovom za iglu.
English: What Inhixa contains
Croatian: Kako Inhixa izgleda i sadržaj pakiranja
English: 2 pre-filled syringes with needle guard 6 pre-filled syringes with needle guard 10 pre-filled syringes with needle guard 12 pre-filled syringes with needle guard 20 pre-filled syringes with needle guard 24 pre-filled syringes with needle guard 30 pre-filled syringes with needle guard 2 pre-filled syringes with UltraSafe Passive needle guard 10 pre-filled syringes with UltraSafe Passive needle guard
Croatian: 2 napunjene štrcaljke sa štitnikom za iglu 6 napunjenih štrcaljki sa štitnikom za iglu 10 napunjenih štrcaljki sa štitnikom za iglu 12 napunjenih štrcaljki sa štitnikom za iglu 20 napunjenih štrcaljki sa štitnikom za iglu 24 napunjenih štrcaljki sa štitnikom za iglu 30 napunjenih štrcaljki sa štitnikom za iglu 2 napunjene štrcaljke sa UltraSafe Passive štitnikom za iglu 10 napunjenih štrcaljki sa UltraSafe Passive štitnikom za iglu
English: 5 mL of solution in clear, colourless type I glass vial sealed with rubber injection stopper and grey aluminium-plastic cap in a cardboard box.
Croatian: 5 ml otopine u bočici od prozirnog, bezbojnog stakla tipa I, s gumenim čepom i sivim zatvaračem od aluminija i plastike u kartonskoj kutiji.
English: Supplied in packs of: - 2, 5, 6, 10, 30 and 50 pre-filled syringes - 2, 5, 6, 10, 20, 30, 50 and 90 pre-filled syringes with needle guard - 2 and 6 pre-filled syringes with UltraSafe Passive needle guard
Croatian: Dostupno u pakiranjima od: - 2, 5, 6, 10, 30 i 50 napunjenih štrcaljki - 2, 5, 6, 10, 20, 30, 50 i 90 napunjenih štrcaljki sa štitnikom za iglu - 2 i 6 napunjenih štrcaljki s UltraSafe Passive štitnikom za iglu
English: Prevention of venous thromboembolic disease associated with surgery Extended prophylaxis of VTE following orthopaedic surgery In a double blind study of extended prophylaxis for patients undergoing hip replacement surgery, 179 patients with no venous thromboembolic disease initially treated, while hospitalized, with enoxaparin sodium 4,000 IU (40 mg) subcutaneously, were randomized to a post-discharge regimen of either enoxaparin sodium 4,000 IU (40 mg) (n=90) once a day subcutaneously or to placebo (n=89) for 3 weeks.
Croatian: U dvostruko slijepom ispitivanju produljene profilakse u bolesnika podvrgnutih kirurškom zahvatu zamjene kuka, 179 bolesnika bez venske tromboembolijske bolesti, koji su prvotno (tijekom hospitalizacije) bili liječeni enoksaparinnatrijem u supkutanoj dozi od 4000 IU (40 mg), randomizirano je da nakon otpusta iz bolnice prima enoksaparinnatrij u dozi od 4000 IU (40 mg) (n=90) supkutano jedanput na dan ili placebo (n=89) tijekom 3 tjedna.
English: 2 pre-filled syringes with needle guard 6 pre-filled syringes with needle guard 10 pre-filled syringes with needle guard 20 pre-filled syringes with needle guard 50 pre-filled syringes with needle guard 90 pre-filled syringes with needle guard 2 pre-filled syringes with UltraSafe Passive needle guard 6 pre-filled syringes with UltraSafe Passive needle guard
Croatian: 2 napunjene štrcaljke sa štitnikom za iglu 6 napunjenih štrcaljki sa štitnikom za iglu 10 napunjenih štrcaljki sa štitnikom za iglu 20 napunjenih štrcaljki sa štitnikom za iglu 50 napunjenih štrcaljki sa štitnikom za iglu 90 napunjenih štrcaljki sa štitnikom za iglu 2 napunjene štrcaljke sa UltraSafe Passive štitnikom za iglu 6 napunjenih štrcaljki sa UltraSafe Passive štitnikom za iglu
English: 0.4 mL of solution in: - a clear, colourless type I neutral glass syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a yellow polypropylene plunger rod.
Croatian: 0,4 ml otopine u: štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i žutim klipom od polipropilena s pričvršćenom iglom i pokrovom za iglu.
English: 1 mL of solution in: - a clear, colourless type I neutral glass graduated syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a black polypropylene plunger rod.
Croatian: 1 ml otopine u: graduiranoj štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i crnim klipom od polipropilena s pričvršćenom iglom i pokrovom za iglu.
English: VTE = venous thromboembolic event (DVT and/or PE) *The 95% Confidence Intervals for the treatment differences for total VTE were: enoxaparin sodium once a day versus heparin (-3.0 to 3.5) enoxaparin sodium every 12 hours versus heparin (-4.2 to 1.7).
Croatian: • PE (%) VTE = venski tromboembolijski događaj (DVT i/ili PE) *Intervali pouzdanosti od 95% za razlike između liječenja za ukupni VTE bili su: enoksaparinnatrij jedanput na dan naspram heparina (-3,0 do 3,5) enoksaparinnatrij svakih 12 sati naspram heparina (-4,2 do 1,7)
English: 0.6 mL of solution in: - a clear, colourless type I neutral glass graduated syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and an orange polypropylene plunger rod.
Croatian: 0,6 ml otopine u: graduiranoj štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i narančastim klipom od polipropilena s pričvršćenom iglom i pokrovom za iglu.
English: 10 mL of solution in clear, colourless type I glass vial sealed with rubber injection stopper and white aluminium-plastic cap in a cardboard box.
Croatian: 10 ml ml otopine u bočici od prozirnog, bezbojnog stakla tipa I, s gumenim čepom i bijelim zatvaračem od aluminija i plastike, u kartonskoj kutiji.
English: 3 mL of solution in clear, colourless type I glass vial sealed with rubber injection stopper and white aluminium-plastic cap in a cardboard box.
Croatian: 3 ml otopine u bočici od prozirnog, bezbojnog stakla tipa I, s gumenim čepom i bijelim zatvaračem od aluminija i plastike u kartonskoj kutiji.
English: 0.8 mL of solution in a clear, colourless type I neutral glass syringe barrel with fixed needle and needle shield closed by chlorobutyl rubber stopper and a purple polypropylene plunger rod.
Croatian: 0,8 ml otopine u: štrcaljki s tijelom od prozirnog, bezbojnog neutralnog stakla tipa I, zatvorenoj čepom od klorbutil-gume i ljubičastim klipom od polipropilena, s pričvršćenom iglom i pokrovom za iglu.
English: Monitoring of platelet counts
Croatian: Praćenje broja trombocita
English: 4,000 IU (40 mg) of Inhixa each day.
Croatian: (40 mg) lijeka Inhixa.
English: Packs of: - 2, 6, 10, 30, 50 and 90 pre-filled syringes - 2, 6, 10, 12, 24 and 30 pre-filled syringes with needle guard - 2 and 10 pre-filled syringes with UltraSafe Passive needle guard
Croatian: Pakiranja od: - 2, 6, 10, 30, 50 i 90 napunjenih štrcaljki - 2, 6, 10, 12, 24 i 30 napunjenih štrcaljki sa štitnika za iglu - 2 i 10 napunjenih štrcaljki sa UltraSafe Passive štitnika za iglu
English: Treatment of acute ST-segment elevation myocardial infarction In a large multicentre study, 20,479 patients with STEMI eligible to receive fibrinolytic therapy were randomized to receive either enoxaparin sodium in a single 3,000 IU (30 mg) intravenous bolus plus a 100 IU/kg (1 mg/kg) subcutaneous dose followed by an subcutaneous injection of 100 IU/kg (1 mg/kg) every 12 hours or intravenous unfractionated heparin adjusted based on aPTT for 48 hours.
Croatian: Bolesnici su bili randomizirani za primanje enoksaparinnatrija u jednokratnoj bolusnoj dozi od 3000 IU (30 mg) intravenski plus 100 IU/kg (1 mg/kg) supkutano, nakon kojih su slijedile supkutane injekcije enoksaparinnatrija u dozi od 100 IU/kg (1 mg/kg) svakih 12 sati, ili za primanje nefrakcioniranog heparina u intravenskoj dozi prilagođenoj prema aPTV-u tijekom 48 sati.
English: Supplied in packs of: - 2, 6, 10, 30, 50 and 90 pre-filled syringes - 2, 6, 10, 12, 24 and 30 pre-filled syringes with needle guard - 2 and 10 pre-filled syringes with UltraSafe Passive needle guard
Croatian: Dostupno u pakiranjima od: - 2, 6, 10, 30, 50 i 90 napunjenih štrcaljki - 2, 6, 10, 12, 24 i 30 napunjenih štrcaljki sa štitnikom za iglu - 2 i 10 napunjenih štrcaljki s UltraSafe Passive štitnikom za iglu
English: Immunoallergic thrombocytope nia
Croatian: Vrlo rijetko: imunoalergijsk a trombocitopeni ja
English: Packs of: - 2, 6, 10, 30 and 50 pre-filled syringes - 2, 6, 10, 12, 20, 24 and 30 pre-filled syringes with needle guard - 2 and 10 pre-filled syringes with UltraSafe Passive needle guard
Croatian: Pakiranja od: - 2, 6, 10, 30 i 50 napunjenih štrcaljki - 2, 6, 10, 12, 20, 24 i 30napunjenih štrcaljki sa štitnika za iglu - 2 i 10 napunjenih štrcaljki sa UltraSafe Passive štitnika za iglu
English: - Changing from blood thinners called vitamin-K antagonists (e.g. warfarin) to Inhixa Stop taking the vitamin-K antagonist.
Croatian: - Prelazak s lijekova za razrjeđivanje krvi koji se zovu antagonisti vitamina K (npr. varfarin) na Inhixu
English: Supplied in packs of: - 2, 6, 10, 30 and 50 pre-filled syringes - 2, 6, 10, 12, 20, 24 and 30 pre-filled syringes with needle guard - 2 and 10 pre-filled syringes with UltraSafe Passive needle guard
Croatian: Dostupno u pakiranjima od: - 2, 6, 10, 30 i 50 napunjenih štrcaljki - 2, 6, 10, 12, 20, 24 i 30 napunjenih štrcaljki sa štitnikom za iglu - 2 i 10 napunjenih štrcaljki s UltraSafe Passive štitnikom za iglu